These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35846120)

  • 1. Conserved 3' UTR of Severe Acute Respiratory Syndrome Coronavirus 2: Potential Therapeutic Targets.
    Park JH; Moon J
    Front Genet; 2022; 13():893141. PubMed ID: 35846120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Therapeutic Effect of Micrornas in Extracellular Vesicles from Mesenchymal Stem Cells against SARS-CoV-2.
    Park JH; Choi Y; Lim CW; Park JM; Yu SH; Kim Y; Han HJ; Kim CH; Song YS; Kim C; Yu SR; Oh EY; Lee SM; Moon J
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-Protein Interaction Analysis of SARS-CoV-2 5' and 3' Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection.
    Verma R; Saha S; Kumar S; Mani S; Maiti TK; Surjit M
    mSystems; 2021 Aug; 6(4):e0064321. PubMed ID: 34254825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant MicroRNA Potential in Targeting Sars-CoV-2 Genome Offering Efficient Antiviral MiRNA-Based Therapies.
    Hajieghrari B; Rahmanian-Koshkaki S
    Microrna; 2022; 11(3):245-262. PubMed ID: 35984027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling the nature's fruit basket to computationally identify Citrus sinensis csi-mir169-3p as a probable plant miRNA against Reference and Omicron SARS-CoV-2 genome.
    Mangukia N; Rao P; Patel K; Pandya H; Rawal RM
    Comput Biol Med; 2022 Jul; 146():105502. PubMed ID: 35605482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
    Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational prediction of potential siRNA and human miRNA sequences to silence orf1ab associated genes for future therapeutics against SARS-CoV-2.
    Hasan M; Ashik AI; Chowdhury MB; Tasnim AT; Nishat ZS; Hossain T; Ahmed S
    Inform Med Unlocked; 2021; 24():100569. PubMed ID: 33846694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the genome of severe acute respiratory syndrome coronavirus 2: implications for COVID-19 severity and progression.
    Al-Qahtani AA
    J Int Med Res; 2022 Mar; 50(3):3000605221086433. PubMed ID: 35352580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence, evolution, and vaccine production approaches of SARS-CoV-2 virus: Benefits of getting vaccinated and common questions.
    Hassanin AA; Haidar Abbas Raza S; Ahmed Ujjan J; Aysh ALrashidi A; Sitohy BM; Al-Surhanee AA; Saad AM; Mohamed Al-Hazani T; Osman Atallah O; Al Syaad KM; Ezzat Ahmed A; Swelum AA; El-Saadony MT; Sitohy MZ
    Saudi J Biol Sci; 2022 Apr; 29(4):1981-1997. PubMed ID: 34924802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Common Deletions in the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.
    Liu Z; Zheng H; Lin H; Li M; Yuan R; Peng J; Xiong Q; Sun J; Li B; Wu J; Yi L; Peng X; Zhang H; Zhang W; Hulswit RJG; Loman N; Rambaut A; Ke C; Bowden TA; Pybus OG; Lu J
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32571797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omicron variant genome evolution and phylogenetics.
    Kandeel M; Mohamed MEM; Abd El-Lateef HM; Venugopala KN; El-Beltagi HS
    J Med Virol; 2022 Apr; 94(4):1627-1632. PubMed ID: 34888894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants.
    Lu J; Yin Q; Pei R; Zhang Q; Qu Y; Pan Y; Sun L; Gao D; Liang C; Yang J; Wu W; Li J; Cui Z; Wang Z; Li X; Li D; Wang S; Duan K; Guan W; Liang M; Yang X
    Virol Sin; 2022 Apr; 37(2):238-247. PubMed ID: 35527227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host microRNA interactions with the SARS-CoV-2 viral genome 3'-untranslated region.
    Frye CJ; Cunningham CL; Mihailescu MR
    bioRxiv; 2023 May; ():. PubMed ID: 37292986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conserved Genomic Terminals of SARS-CoV-2 as Co-evolving Functional Elements and Potential Therapeutic Targets.
    Chan AP; Choi Y; Schork NJ
    bioRxiv; 2020 Jul; ():. PubMed ID: 32676601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Silico analysis reveals lower transcription efficiency of C241T variant of SARS-CoV-2 with host replication factors MADP1 and hnRNP-1.
    Chaudhari A; Chaudhari M; Mahera S; Saiyed Z; Nathani NM; Shukla S; Patel D; Patel C; Joshi M; Joshi CG
    Inform Med Unlocked; 2021; 25():100670. PubMed ID: 34307830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.
    Noor R; Shareen S; Billah M
    Bull Natl Res Cent; 2022; 46(1):96. PubMed ID: 35431535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Comparative Analysis of the Functional, Structural, and Evolutionary Properties of SARS-CoV-2 Variant Spike Proteins.
    Math RK; Mudennavar N; Javaregowda PK; Savanur A
    JMIR Bioinform Biotechnol; 2022; 3(1):e37391. PubMed ID: 35669291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.